Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MyoMeasure study of myotonia measurements in DM1
NL-OMON61129Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mexiletine in myotonic dystrophy type 1 (DM1), sponsored by Radboud University Medical Center. Primary endpoints: Handgrip relaxation time, Video hand opening time and 3 more. Started Jul 2026; status: recruiting.
02
Drugs
mexiletine
03
Conditions
myotonic dystrophy type 1 (DM1)
Beyond the preview
Go deeper on NL-OMON61129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61129.